Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNY    source : Www.algernonpharmaceuticals.com    save search
Streetwise Reports – Patients in Algernon’s Phase 2a Study Show Improved Lung Capacity
Published: 2022-07-20 (Crawled : 14:00) - algernonpharmaceuticals.com
AGNPF | $0.089 75K twitter stocktwits trandingview |
Health Technology
 | | O: -2.62% H: 3.0% C: 2.89%
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
 | | O: -0.62% H: 0.0% C: 0.0%
capacity study phase 2b
Pulmonary Fibrosis News – NP-120, Potential IPF Treatment, Stabilizes Lung Function in Trial
Published: 2022-07-20 (Crawled : 14:00) - algernonpharmaceuticals.com
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
 | | O: -0.62% H: 0.0% C: 0.0%
np-120 fibrosis trial potential
Gainers vs Losers
59% 41%

Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M twitter stocktwits trandingview |
Consumer Services
CZOO | $11.685 134.17% 7.6M twitter stocktwits trandingview |

BOF | $1.93 64.96% 55M twitter stocktwits trandingview |

AMST | $3.14 57.0% 59M twitter stocktwits trandingview |
Technology Services
TROO | $1.57 44.04% 2.8M twitter stocktwits trandingview |
Manufacturing
LICN | $0.7885 40.8% 11M twitter stocktwits trandingview |

MULN | News | $3.7 35.53% 6.4M twitter stocktwits trandingview |
Information
WHLM | $6.61 30.12% 400K twitter stocktwits trandingview |
Commercial Services
RILY | $27.91 28.5% 8.9M twitter stocktwits trandingview |
Finance
RBBN 4 | $3.25 26.46% 1.5M twitter stocktwits trandingview |
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.